Synchron · The Techno Optimist

Analyst view

First company FDA-cleared to trial a permanent brain implant (2021); its US study met its safety goal in six patients (2024).
Raised $200M in Nov 2025 for a main trial, launch prep and a next-generation device with more channels.
Works with Apple's brain-interface standard since 2025, for direct control of iPhone and iPad.

As reported

Access

A doctor threads a thin tube from the neck vein to a large vein on top of the brain, next to the movement area, much like fitting a heart stent.

Sensor

A self-opening metal mesh carries 16 electrodes that press on the vein wall and pick up brain activity through it.

Telemetry

A wire runs through the vein to a unit under the collarbone, which powers the device and sends data out wirelessly.

Decoding

Attempted movements, like tapping a foot, create signals turned into clicks and selections rather than smooth, fine control.

Programs

Synchron, one program

Updated 1 Apr 2026

Research · Proto · Pilot · Deploy · Scaling

2 items

Open · Active · Partial

Low bandwidthActive research
Recording through a vein wall with 16 electrodes gives far less information than electrodes in the brain, so it's slower.
Only where veins areOpen
It can only sit where big veins run, which limits which brain areas it can reach.

Minimally invasive BCIs · 1

2 rounds · as reported

Date	Round	Amount	Post-money	Lead
6 Nov 2025	Series D	$200M	—	—
Dec 2022	Series C	$75M	—	—

3 partners

Partner
Mount Sinai (opens mountsinai.org)
Site of the first US Stentrode implant in COMMAND.
Partner
Apple (opens apple.com)
Early adopter of Apple's BCI Human Interface Device protocol.
Partner
NVIDIA
Uses NVIDIA platforms for its Chiral neural foundation model work.

Key people